A new ctDNA‑guided colorectal cancer trial is focusing on patients who finish treatment with no visible disease yet still carry molecular traces of cancer in their bloodstream.
This early‑intervention strategy uses TTX‑MC138, a therapy designed to block a microRNA linked to tumor invasion and recurrence.
Visit Banish Cancer Blog for more.
#ColorectalCancer #CancerResearch #HealthEquity #BanishCancer #Oncology